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No compelling evidence that more physically attractive young adult 
women have higher estradiol or progesterone 
 
Abstract 
Putative associations between sex hormones and attractive physical 
characteristics in women are central to many theories of human physical 
attractiveness and mate choice. Although such theories have become very 
influential, evidence that physically attractive and unattractive women have 
different hormonal profiles is equivocal. Consequently, we investigated 
hypothesized relationships between salivary estradiol and progesterone and 
two aspects of women’s physical attractiveness that are commonly assumed 
to be correlated with levels of these hormones: facial attractiveness (N=249) 
and waist-to-hip ratio (N=247). Our analyses revealed no compelling evidence 
that women with more attractive faces or lower (i.e., more attractive) waist-to-
hip ratios had higher levels of estradiol or progesterone. One analysis did 
suggest that women with more attractive waist-to-hip ratios had significantly 
higher progesterone, but the relationship was weak and the relationship not 
significant in other analyses. These results do not support the influential 
hypothesis that between-women differences in physical attractiveness are 
related to estradiol and/or progesterone. 
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1. Introduction 
Many researchers have hypothesized that human attractiveness judgments 
are psychological adaptations for identifying high-quality mates (Grammer et 
al., 2003; Little et al., 2011; Thornhill & Gangestad, 1999). Researchers have 
also hypothesized that fertility, as indexed by high levels of estradiol and/or 
progesterone, is a particularly important aspect of women's mate quality 
(Grammer et al., 2003; Little et al., 2011; Thornhill & Gangestad, 1999). 
Although this proposal has become very influential in the human 
attractiveness and mate choice literatures, evidence that more physically 
attractive women have higher estradiol or progesterone is equivocal (Grillot et 
al., 2014; Jasienska et al., 2004; Law Smith et al., 2006; Puts et al., 2013). 
 
Two studies have investigated putative relationships between women's facial 
attractiveness and hormone levels. Law Smith et al. (2006) reported a 
significant positive correlation between ratings of women's facial 
attractiveness and estradiol. They also reported a positive correlation between 
facial attractiveness and progesterone, although this relationship was not 
significant. By contrast with Law Smith et al's results, Puts et al. (2013) found 
no evidence that women with higher levels of either estradiol or progesterone 
possessed more attractive faces. To date, evidence that more facially 
attractive women have higher estradiol or progesterone is therefore 
inconclusive.  
 
Other studies have tested for evidence that women's physical attractiveness 
is positively correlated with estradiol or progesterone by investigating the 
hormonal correlates of women's waist-to-hip ratio. Jasienska et al. (2004) 
reported that women with lower (i.e., more attractive) waist-to-hip ratios had 
higher estradiol and higher progesterone. However, Grillot et al. (2014) found 
no evidence for these relationships. To date, evidence that waist-to-hip ratio is 
associated with sex hormones is therefore also inconclusive.  
 
Given the importance of associations between hormone levels and 
attractiveness for theories of women’s attractiveness and mate choice, we 
tested for the hypothesized correlations between salivary estradiol and 
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progesterone and both women's facial attractiveness and waist-to-hip ratio. 
Our study is the largest to date to test for putative associations between 
women's physical attractiveness and measured hormone levels. Our sample 
is more than eight times larger than that in Law-Smith et al. (2006) and more 
than twice as large as that in Jasienska et al. (2004). 
 
2. Methods 
2.1. Participants 
We recruited 249 young adult white women for the study (mean age=21.5 
years, SD=3.30 years). All participants were students at the University of 
Glasgow and each completed five weekly test sessions. Participants were 
recruited only if they were not currently using any hormonal supplements 
(e.g., oral contraceptives), had not used any form of hormonal supplements in 
the 90 days prior to their participation, and had never used sunbeds or 
tanning products. None of the participants reported being pregnant, having 
been pregnant recently, or breastfeeding. Women participated as part of a 
larger study on hormonal correlates of women’s behavior (Jones et al., in 
press a, in press b, in press c).  
 
2.2. Face photography and ratings 
In each of the five test sessions, each participant first cleaned her face with 
hypoallergenic face wipes to remove any makeup. Makeup was removed 
because Law Smith et al. (2006) reported that estradiol and progesterone 
predicted facial attractiveness in a sample of women not wearing makeup, but 
not in a sample of women wearing makeup. A full-face digital photograph was 
taken a minimum of 10 minutes later. Photographs were taken in a small 
windowless room against a constant background, under standardized diffuse 
lighting conditions, and participants were instructed to pose with a neutral 
expression. Camera-to-head distance and camera settings were held 
constant. Participants wore a white smock covering their clothing when 
photographed to control for possible effects of reflectance from clothing. 
Photographs were taken using a Nikon D300S digital camera and a 
GretagMacbeth 24-square ColorChecker chart was included in each image for 
use in color calibration.  
 5 
 
Following Jones et al. (2015), face images were color calibrated using a least-
squares transform from an 11-expression polynomial expansion developed to 
standardize color information across images (Hong et al., 2001). Note that 
color calibration of face images eliminates differences across images due to 
subtle variation in factors such as lighting. It does not reduce differences 
among images in other aspects of facial coloration. For example, even subtle 
hormone-linked differences in facial coloration can be measured in images 
calibrated in this way (Jones et al., 2015). Each image was standardized on 
pupil positions and masked so that hairstyle and clothing were not visible. The 
1245 face images (five images for each of the 249 women) were then rated 
for attractiveness using a 1 (much less attractive than average) to 7 (much 
more attractive than average) scale by 14 men and 14 women. Inter-rater 
agreement for these ratings was high (Cronbach’s alpha=.93). Trial order was 
fully randomized. The screen was calibrated using an xRite i1 Display Pro 
colorimeter prior to testing. Simulations (see DeBruine & Jones, 2018) 
sampling from a population of 2513 raters, each of whom had rated the 
attractiveness of 102 faces, indicate that >99% of 1000 random samples of 15 
raters produced Cronbach’s alphas >.8, indicating high reliability of ratings 
(90% of all alphas were >.85). Furthermore, increasing the number of raters 
providing attractiveness ratings has a negligible effect on the mean 
attractiveness ratings once ratings have been collected from 28 raters 
(Hehman et al., 2018).  
 
2.3. Hormone assays 
Participants provided a saliva sample via passive drool (Papacosta & Nassis, 
2011) in each test session. Participants were instructed to avoid consuming 
alcohol and coffee in the 12 hours prior to participation and avoid eating, 
smoking, drinking, chewing gum, or brushing their teeth in the 60 minutes 
prior to participation. Saliva samples were frozen immediately and stored at -
32°C until being shipped, on dry ice, to the Salimetrics Lab (Suffolk, UK) for 
analysis, where they were assayed using the Salivary 17β-Estradiol Enzyme 
Immunoassay Kit 1-3702 (M=3.42 pg/mL, SD=1.33 pg/mL; intra-assay 
CV=7.13%; inter-assay CV=7.45%) and Salivary Progesterone Enzyme 
 6 
Immunoassay Kit 1-1502 (M=143.90 pg/mL, SD=93.33 pg/mL; intra-assay 
CV=6.2%; inter-assay CV=7.55%). Hormone levels more than three standard 
deviations from the sample mean for that hormone or where Salimetrics 
indicated levels were outside the assay sensitivity range were excluded from 
the dataset (~1.5% of hormone measures were excluded). Reliability of 
hormone levels across test sessions was good for both estradiol (Cronbach’s 
alpha=.90; Intraclass correlation coefficient=.46) and progesterone 
(Cronbach’s alpha=.91; Intraclass correlation coefficient=.58). 
 
2.4. Body measures 
In one of the five test sessions, waist and hip circumferences were measured 
from 247 of the women by one researcher. Two women chose not to have 
waist and him circumferences measured. Waist and hip circumferences were 
used to calculate waist-to-hip ratio (M=0.75, SD=0.05).  
 
3. Results 
A linear mixed model was used to investigate the relationship between facial 
attractiveness and hormone levels. Analyses were conducted using R version 
3.3.2 (R Core Team, 2016), with lme4 version 1.1-13 (Bates et al., 2014) and 
lmerTest version 2.0-33 (Kuznetsova et al., 2013). To create mean (i.e., trait) 
hormone values for our analyses, hormone levels were averaged across test 
sessions for each woman, centered on the grand mean, and scaled so the 
majority of the distribution for each hormone varied from -.5 to .5 (this was 
done by dividing values by a constant, is done simply to facilitate calculations 
in the linear mixed models, and has no material effect on the results). To 
create current (i.e., state) hormone values for our analyses, values for each 
hormone were centered on their subject-specific means and scaled using the 
same scaling constants as above. The linear mixed model predicted face 
image ratings with current (i.e., state) estradiol, current (i.e., state) 
progesterone, rater sex (effected coded so that +0.5 was male and -0.5 was 
female), and their interactions entered as predictors. Mean (i.e., trait) 
estradiol, mean (i.e., trait) progesterone, rater sex, and their interactions were 
also entered as predictors. Interactions between estradiol and progesterone 
were included following Puts et al. (2013). Random intercepts were specified 
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for rater, stimulus woman (i.e., each woman whose face images were used as 
stimuli), and individual face image. Random slopes were specified maximally, 
following Barr et al. (2013) and Barr (2013). The model is fully described in 
our supplemental materials, along with results of simplified models testing for 
effects of current and mean hormone levels separately (see 
https://osf.io/qd9bv/). Data are also available at https://osf.io/qd9bv/. Full 
results are shown in Table 1.  
 
Table 1. Results of linear mixed model testing for within-woman and between-women 
hormone-attractiveness correlations. 
 
 estimate 95% CI SE t p 
current estradiol -0.01 -0.10, 0.08 0.05 -0.23 .82 
current progesterone -0.07 -0.14, 0.01 0.04 -1.66 .10 
rater sex -0.70 -1.20, -0.20 0.26 -2.73 .01 
mean estradiol -0.15 -0.56, 0.26 0.21 -0.73 .47 
mean progesterone -0.06 -0.63, 0.51 0.29 -0.21 .83 
current estradiol x current 
progesterone 
-0.54 -1.01, -0.06 0.24 -2.20 .03 
current estradiol x rater sex 0.02 -0.13, 0.17 0.08 0.23 .82 
current progesterone x rater 
sex 
-0.02 -0.16, 0.11 0.07 -0.36 .72 
mean estradiol x mean 
progesterone 
0.69 -1.70, 3.08 1.22 0.56 .57 
mean estradiol x rater sex -0.00 -0.11, 0.11 0.05 -0.01 .99 
mean progesterone x rater sex -0.09 -0.24, 0.06 0.08 -1.17 .24 
current estradiol x current 
progesterone x rater sex 
0.42 -0.45, 1.28 0.44 0.94 .36 
mean estradiol x mean 
progesterone x rater sex 
0.23 -0.65, 1.11 0.45 0.52 .61 
 
No between-women hormone-attractiveness correlations were significant. 
However, there was a significant interaction between the effects of current 
estradiol and current progesterone (estimate=-0.54, 95% CI=-1.01, -0.06, 
SE=0.24, t=-2.20, p=.030). Although weak, this interaction indicated that 
within-woman attractiveness was particularly high both when current estradiol 
was high and current progesterone was simultaneously low and when current 
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estradiol was low and current progesterone was simultaneously high (see 
Figure 1). 
 
Figure 1. The interaction between current estradiol and current progesterone. The heat map 
shows predicted values for attractiveness based on the model tested and for the range of 
estradiol and progesterone values in our dataset. 
 
Since we had only one waist-to-hip ratio measure for each woman, we simply 
tested for significant correlations between waist-to-hip ratio and both mean 
estradiol and mean progesterone. There was a significant positive correlation 
between waist-to-hip ratio and mean estradiol (r=.23, 95% CI=.11, .34, 
N=247, p<.001). The correlation between waist-to-hip ratio and mean 
progesterone was not significant (r=-.07, 95% CI=-.20, 0.05, N=247, p=.24). 
 
Next, we repeated the between-women analyses of facial attractiveness and 
waist-to-hip ratio, this time controlling for between-women differences in body 
mass index (BMI). Although we observed between-women hormone-BMI 
correlations, controlling for BMI did not alter the patterns of results described 
above. These analyses are described in full in our supplemental materials 
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(https://osf.io/qd9bv/). One woman chose not to have her height and weight 
measurements taken so her data could not be included in these analyses. 
 
In addition to the analyses described above, we investigated the relationships 
between attractiveness and average hormone levels and between WHR and 
average hormone levels using a Bayesian analysis with a multivariate latent 
model. Details of this analysis and full results are reported at 
https://osf.io/qd9bv/. The repeated measurement for each female subject 
(estradiol and progesterone) and the repeated measurement from the raters 
were modeled as the realization of the unobserved latent variables with a 
mixed effect formulation. Similar to the results above, the correlation between 
waist-to-hip ratio and the latent estradiol level was estimated at r=.261 [.138, 
.386] (bracket shows 95% highest posterior density interval). The correlation 
between waist-to-hip ratio and the latent progesterone was r=-.022 [-.160, 
.113]. The correlation between the latent estradiol level and latent 
attractiveness rating was r=-.044 [-.182, .087]. The correlation between the 
latent progesterone level and latent attractiveness rating was r=-.077 [-.215, 
.058].  
 
In response to a reviewer’s suggestions, we tested for correlations between 
hormone levels and both attractiveness and waist-to-hip ratio using each 
participant’s maximum progesterone level and maximum estradiol level. We 
did this to address concerns about the extent to which average hormone 
levels might be biased by some participants being tested more often in 
particular cycle phases. These analyses showed no significant relationships 
between maximum hormone levels and facial attractiveness (both absolute 
r<.03, both p>.64). Consistent with our previous analyses, women with higher 
maximum estradiol had significantly higher waist-to-hip ratios (r=.16, p<.010). 
Although the relationship was weak, women with higher maximum 
progesterone had significantly lower waist-to-hip ratios (r=-.14, p=.020). 
However, restricting the data set to women with maximum progesterone 
levels greater than 250 pg/mL (i.e., those showing evidence of having 
ovulated prior to their maximum progesterone level being measured) altered 
the pattern of results for waist-to-hip ratio, however. In these analyses, 
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women with higher maximum estradiol still had significantly higher waist-to-hip 
ratios (r=.31, p<.001), but the relationship between maximum progesterone 
waist-to-hip ratio was now not significant (r=-.05, p=.63). That the correlation 
between progesterone and waist-to-hip ratio was only significant in one of our 
analyses suggests it is not robust. 
 
4. Discussion 
Here we investigated possible relationships between salivary estradiol and 
progesterone and both women's facial attractiveness and waist-to-hip ratio. 
We carried out these analyses to test the influential hypothesis that more 
physically attractive women have higher estradiol and progesterone 
(Jasienska et al., 2005; Law Smith et al., 2006). We found no compelling 
evidence that women with higher facial attractiveness or lower (i.e., more 
attractive) waist-to-hip ratios had higher levels of estradiol or progesterone1. 
In fact, we actually found that women with higher (i.e., relatively unattractive) 
waist-to-hip ratios had higher levels of estradiol. Thus, our results do not 
replicate those of previous studies with smaller sample sizes reporting 
significant correlations between hormone levels and either facial 
attractiveness (Law Smith et al., 2006) or waist-to-hip ratio (Jasienska et al., 
2004). Our results do not then support the influential hypothesis that between-
woman differences in physical attractiveness are correlated with estradiol 
and/or progesterone. The Bayesian analyses we carried out also supported 
this conclusion. 
 
We observed no evidence that more attractive women had higher estradiol or 
progesterone levels. However, our analysis of facial attractiveness ratings 
suggested that within-woman changes in facial attractiveness were 
associated with within-woman changes in hormone levels. Women's facial 
attractiveness subtly increased both when current estradiol was high and 
current progesterone was simultaneously low and when current estradiol was 
                                                        
1 Although one analysis showed a significant negative correlation between maximum 
progesterone and waist-to-hip ratio, the correlation was weak and not evident in our other 
analyses. This pattern of results suggests the relationship between progesterone and waist-
to-hip ratio is not robust and may be a false positive, 
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low and current progesterone was simultaneously high. This result partially 
replicates Puts et al. (2013), who found that attractiveness was increased 
when current estradiol was high and current progesterone was simultaneously 
low.  
 
The combination of high estradiol and low progesterone is characteristic of the 
fertile phase of the menstrual cycle (Gangestad & Haselton, 2015). 
Consequently, Puts et al. (2013) proposed that the increased attractiveness 
that they observed when women were in this hormonal state supported the 
hypothesis that women's attractiveness subtly increases during the fertile 
phase of the menstrual cycle. However, Puts et al. (2013) compared 
attractiveness during the late follicular and mid-luteal phases of the menstrual 
cycle only. Because relatively high levels of both progesterone and estradiol 
characterize the mid-luteal phase of the menstrual cycle, Puts et al. (2013) 
are unlikely to have sampled women when estradiol was low and 
progesterone was simultaneously high. By contrast, we sampled women at 
weekly intervals over an entire menstrual cycle, allowing us to capture a 
greater range of hormonal states. Importantly, our results showing that 
attractiveness increased both when current estradiol was high and current 
progesterone was simultaneously low and when current progesterone was 
high and current estradiol was simultaneously low suggest that hormone-
linked increases in facial attractiveness are not necessarily unique to 
hormonal states associated with high fertility. Thus, our results for within-
woman hormone-attractiveness correlations do not necessarily support the 
hypothesis that hormone-linked within-woman changes in attractiveness are 
fertility signals or the hypothesis that they are imperfectly concealed cues of 
ovulatory status (see Haselton & Gildersleeve, 2016 for a discussion of these 
two hypotheses). Although we acknowledge that the combination of high 
levels of progesterone and low levels of estradiol is a relatively unusual 
combination of hormone levels in textbook plots of hormonal changes over the 
menstrual cycle, graphing the distribution of these hormones in our dataset 
suggests it is not particularly uncommon in our sample. This is consistent with 
other recent work suggesting that only ~38% of young adult women show 
textbook hormonal profiles (see Marcinkowska et al., 2018). 
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Havlicek et al. (2015a, 2015b) posited that within-woman hormone-
attractiveness correlations might simply be functionless byproducts of 
between-women hormone-attractiveness correlations. We agree with Havlicek 
et al. that the within-subject changes in attractiveness observed in the current 
study (and in other studies reporting changes in facial attractiveness during 
the menstrual cycle) may be too subtle to directly influence men’s mate 
choices. Nonetheless, that we observed significant within-woman, but not 
between-women, hormone-attractiveness correlations does not support 
Havlicek et al’s hypothesis that within-woman hormone-attractiveness 
correlations are functionless byproducts of between-women hormone-
attractiveness correlations. We note here that, while we suggest that within-
woman hormone-attractiveness correlations are unlikely to simply be 
functionless byproducts of between-women hormone-attractiveness 
correlations, we remain open to the possibility that they are functionless 
byproducts of within-woman hormonal changes, rather than fertility signals. 
 
Could differences in methodologies across studies explain the inconsistent 
results for hormone-attractiveness correlations? For example, Law-Smith et 
al. (2006) and Jasienska et al. (2004) both controlled for effects of cycle-
linked within-woman variation in hormone levels when testing for between-
women hormone-attractiveness correlations. Law-Smith et al. (2006) did this 
by measuring estradiol and progesterone from the late follicular and luteal 
menstrual cycle phases, respectively. Jasienska et al. (2004) did this by 
averaging hormone levels measured daily and also by considering luteal-
phase progesterone levels only. Thus, the differences between our findings 
and their results could be due to the possible effects of cycle phase on 
between-women hormone differences being less well controlled in our study 
than in Jasienska et al. (2004) and Law-Smith et al. (2006). Although the logic 
of this explanation is appealing, we think this explanation is unlikely, Our 
results are consistent with those of other studies that controlled for effects of 
cycle-linked changes in hormone levels when investigating the between-
women hormone-attractiveness correlations, but also found no compelling 
evidence that more attractive women had higher levels of estradiol or 
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progesterone (Grillot et al., 2014; Puts et al., 2013).  
 
The positive correlation between estradiol and waist-to-hip ratio that we 
observed in the current study is surprising. However, we note that the pattern 
of results across studies on this issue (i.e., the negative correlation reported 
by Jasienska et al., the null result reported by Grillot et al., and the positive 
correlation observed in the current study) is arguably what one would expect if 
there are no reliable correlations between waist-to-hip ratio and these sex 
hormones (i.e., we suggest that both the positive correlation in our study and 
the negative correlation reported by Jasienska et al. may both be false 
positives). We also suggest that it is unlikely that our non-replication of 
Jasienska et al’s results for waist-to-hip ratio are a consequence of having 
only a single measurement of waist-to-hip ratio taken by an individual 
researcher for each woman. While taking more measurements could reduce 
measurement error, it is unlikely that this source of error is causing the 
strikingly different patterns of results seen in Jasienska et al. and the current 
study. 
 
In conclusion, our analyses provide no compelling evidence that women with 
more attractive faces or waist-to-hip ratios have higher estradiol or 
progesterone. Importantly, these null results do not support the popular and 
influential hypothesis that women’s physical attractiveness is a marker for 
their estradiol and/or progesterone levels, at least among young adult women. 
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